报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-06-30 | -1.41% | -229.36% | -213.33% | 59/69 | 3.35% | 羚锐制药 | 13.67% | 行业排名> |
2025-03-31 | -0.45% | -130% | 46.43% | 61/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
2024-12-31 | -0.84% | -127.27% | -146.67% | 52/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
2024-09-30 | 1.8% | -54.31% | 65.14% | 52/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
2024-06-30 | 1.09% | -50.45% | -27.33% | 49/69 | 0.66% | 羚锐制药 | 13.25% | 行业排名> |
2024-03-31 | 1.5% | -22.28% | -51.3% | 41/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
2023-12-31 | 3.08% | -3.45% | -21.83% | 48/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
2023-09-30 | 3.94% | -2.96% | 79.09% | 47/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
2023-06-30 | 2.2% | 9.45% | 13.99% | 53/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
2023-03-31 | 1.93% | 9.04% | -39.5% | 47/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
2022-12-31 | 3.19% | -79.56% | -21.43% | 46/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
2022-09-30 | 4.06% | -65.74% | 101.99% | 43/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
2022-06-30 | 2.01% | -74.46% | 13.56% | 49/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
2022-03-31 | 1.77% | 2% | -88.66% | 41/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
2021-12-31 | 15.61% | -18.57% | 31.73% | 8/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
2021-09-30 | 11.85% | -19.93% | 50.57% | 12/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
2021-06-30 | 7.87% | 2% | -58.95% | 11/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
2020-12-31 | 19.17% | -28.28% | 29.53% | 4/69 | 0.1% | 片仔癀 | 13.23% | 行业排名> |
2020-09-30 | 14.8% | 2% | -44.63% | 4/69 | 6.79% | *ST长药 | 7.37% | 行业排名> |
2019-12-31 | 26.73% | -12.56% | -12.56% | 2/69 | 5.86% | 沃华医药 | 22.84% | 行业排名> |
2018-12-31 | 30.57% | 2% | 2% | 2/69 | 7.87% | 沃华医药 | 19.47% | 行业排名> |